The University of Oxford, which is partnering with large-cap pharma AstraZeneca plc to develop a vaccine for SARS-CoV-2, could lead the pack in advancing its vaccine candidate to the next stage.

The university is one of the eight companies and institutions that have advanced their candidates to human testing, according to the latest World Health Organization statistics.

Phase 1 Results In Mid-June

About 1,000 people have been vaccinated in the first phase of the vaccine program, which is going as planned and without safety scares, Prof. John Bell, regius professor of medicine at the Oxford University, reportedly told BBC Radio 4’s Today program.

Results of the Phase 1/2 trial that is underway could be available by mid-June, Bell said.

“We also want to make sure that the rest of the world will be ready to make this vaccine at scale so that it gets to populations in developing countries, for example, where the need is very great.” CLICK for complete article